Skip to content

Selegiline

Selegiline (Emsam) appears in two listed tablets, the named brand and Eldepryl. Their recorded uses are distinct: Emsam is associated with major depression, while Eldepryl is used in Parkinson’s disease. Product-specific formulation and directions therefore matter. Listed products differ in ingredient profile, form, strength, and pack size.

Emsam

Major Depressive Disorder

5mg

Developed to mitigate severe depressive symptoms to support psychiatric recovery and target monoamine neurotransmitters.

From$2.42/ tabletView

Eldepryl

Parkinson's Disease

5mg · 10mg

Designed to support dopamine pathways to manage parkinsonian motor deficits and alleviate muscle stiffness.

From$0.63/ tabletView

How does selegiline work?

A monoamine oxidase inhibitor, selegiline slows the breakdown of chemical messengers in the brain. One product addresses Major Depressive Disorder, while the other is used for Parkinson’s Disease.

Important safety information for Selegiline

Information about Selegiline on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.